Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 1

Conditions

Waldenstrom Macroglobulinemia 1

Interventions

zanubrutinib 3Rituximab 3Bendamustine Hydrochloride 3ibrutinib 2talquetamab 1pirtobrutinib 1Sra protein, Drosophila 1Specimen Handling 1Sirolimus 1Prednisone 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Everolimus 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Waldenstrom Macroglobulinemia × Sra protein, Drosophila × Clear all
NCT07464210 2026-03-11

Nemtabrutinib, Bortezomib, and Rituximab for WM

Seoul National University Hospital

Phase 2 Not yet recruiting
19 enrolled
Lymphoid

Waldenstrom Macroglobulinemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡